Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
U.S. official says COVID-19 vaccine output to start by end of summer, CNBC says » 19:22
07/13/20
07/13
19:22
07/13/20
19:22
BNTX

BioNTech

$77.73 /

+7.315 (+10.39%)

, PFE

Pfizer

$35.22 /

+1.38 (+4.08%)

, INO

Inovio

$25.57 /

+2.21 (+9.46%)

, JNJ

Johnson & Johnson

$145.30 /

+2.85 (+2.00%)

, MRNA

Moderna

$71.72 /

+9.15 (+14.62%)

, SPY

SPDR S&P 500 ETF Trust

$314.80 /

-2.81 (-0.88%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

, NVAX

Novavax

$104.46 /

+10.1 (+10.70%)

, MRK

Merck

$77.38 /

+0.64 (+0.83%)

, SNY

Sanofi

$50.96 /

+0.64 (+1.27%)

, GSK

GlaxoSmithKline

$40.07 /

+0.16 (+0.40%)

A senior Trump…

A senior Trump administration official said that U.S. health officials and drugmakers anticipate starting to make potential COVID-19 vaccine doses by the end of the summer, CNBC's Berkeley Lovelace, Jr. reports. The U.S. is seeking to deliver 300M doses of a coronavirus vaccine by early 2021, and the manufacturing process is already underway even though they aren't sure which vaccine, if any, will be effective, the author says, citing a senior Trump administration official. "Exactly when the vaccine materials will be in production and manufacturing? It's probably four to six weeks away," the official said on a call with reporters, which was hosted by the Department of Health and Human Services. "But we will be actively manufacturing by the end of the summer." Publicly traded companies working on vaccines include Moderna (MRNA), Johnson & Johnson (JNJ), Inovio (INO), Pfizer (PFE), BioNTech (BNTX), Novavax (NVAX), Merck (MRK), Sanofi (SNY), and GlaxoSmithKline (GSK). Reference Link

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

SNY Sanofi
$50.96 /

+0.64 (+1.27%)

PFE Pfizer
$35.22 /

+1.38 (+4.08%)

NVAX Novavax
$104.46 /

+10.1 (+10.70%)

MRNA Moderna
$71.72 /

+9.15 (+14.62%)

MRK Merck
$77.38 /

+0.64 (+0.83%)

JNJ Johnson & Johnson
$145.30 /

+2.85 (+2.00%)

INO Inovio
$25.57 /

+2.21 (+9.46%)

GSK GlaxoSmithKline
$40.07 /

+0.16 (+0.40%)

BNTX BioNTech
$77.73 /

+7.315 (+10.39%)

BNTX BioNTech
$77.73 /

+7.315 (+10.39%)

07/13/20 Canaccord
BioNTech price target raised to $75 from $60 at Canaccord
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
07/02/20 BMO Capital
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital
07/02/20 SVB Leerink
BioNTech price target raised to $42 from $37 at SVB Leerink
PFE Pfizer
$35.22 /

+1.38 (+4.08%)

07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
INO Inovio
$25.57 /

+2.21 (+9.46%)

07/01/20
Fly Intel: Top five analyst downgrades
07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
07/01/20 Roth Capital
Roth 'unimpressed' with Inovio data, downgrades to Sell with $11 target
07/01/20 Maxim
Inovio downgraded to Hold from Buy at Maxim
JNJ Johnson & Johnson
$145.30 /

+2.85 (+2.00%)

07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
07/13/20 H.C. Wainwright
Pacira price target raised to $68 from $63 at H.C. Wainwright
07/10/20 Jefferies
Pacira price target raised to $69 from $53 at Jefferies
07/06/20 Baird
Cooper Companies downgraded to Neutral, Baird see confluence of issues
MRNA Moderna
$71.72 /

+9.15 (+14.62%)

07/13/20 Brookline
Moderna initiated with a Buy at Brookline
07/13/20 Jefferies
Jefferies starts Moderna with Buy rating, $90 price target
07/08/20 Piper Sandler
Piper reiterates $100 target on Moderna after Phase II study enrolled
SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPX S&P 500
$0.00 /

+ (+0.00%)

NVAX Novavax
$104.46 /

+10.1 (+10.70%)

07/08/20
Fly Intel: Top five analyst downgrades
07/08/20 Ladenburg
Novavax downgraded to Neutral from Buy at Ladenburg
07/07/20 Cantor Fitzgerald
Novavax price target raised to $148 from $88 at Cantor Fitzgerald
MRK Merck
$77.38 /

+0.64 (+0.83%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
SNY Sanofi
$50.96 /

+0.64 (+1.27%)

07/08/20 Piper Sandler
Piper upgrades Kiadis on 'platform validating' Sanofi deal
07/06/20 Citi
BioMarin price target raised to $148 from $105 at Citi
07/01/20 Roth Capital
Applied Genetic may attract Sanofi takeover interest, says Roth Capital
06/26/20 SunTrust
Translate Bio initiated with a Buy at SunTrust
GSK GlaxoSmithKline
$40.07 /

+0.16 (+0.40%)

07/13/20 UBS
UBS reiterates Buy on GSK as FDA belantamab docs are out
07/13/20 JPMorgan
Ideaya upgraded to Overweight on recent pullback at JPMorgan
06/19/20 Barclays
Glaxo belantamab AdCom a surprise, supports cautious view, says Barclays
SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

SNY Sanofi
$50.96 /

+0.64 (+1.27%)

PFE Pfizer
$35.22 /

+1.38 (+4.08%)

NVAX Novavax
$104.46 /

+10.1 (+10.70%)

MRNA Moderna
$71.72 /

+9.15 (+14.62%)

MRK Merck
$77.38 /

+0.64 (+0.83%)

JNJ Johnson & Johnson
$145.30 /

+2.85 (+2.00%)

INO Inovio
$25.57 /

+2.21 (+9.46%)

GSK GlaxoSmithKline
$40.07 /

+0.16 (+0.40%)

BNTX BioNTech
$77.73 /

+7.315 (+10.39%)

  • 19
    May
  • 12
    Feb
  • 06
    Feb
  • 10
    Oct
SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

SNY Sanofi
$50.96 /

+0.64 (+1.27%)

PFE Pfizer
$35.22 /

+1.38 (+4.08%)

NVAX Novavax
$104.46 /

+10.1 (+10.70%)

MRNA Moderna
$71.72 /

+9.15 (+14.62%)

MRK Merck
$77.38 /

+0.64 (+0.83%)

JNJ Johnson & Johnson
$145.30 /

+2.85 (+2.00%)

INO Inovio
$25.57 /

+2.21 (+9.46%)

GSK GlaxoSmithKline
$40.07 /

+0.16 (+0.40%)

BNTX BioNTech
$77.73 /

+7.315 (+10.39%)

SNY Sanofi
$50.96 /

+0.64 (+1.27%)

NVAX Novavax
$104.46 /

+10.1 (+10.70%)

MRNA Moderna
$71.72 /

+9.15 (+14.62%)

MRK Merck
$77.38 /

+0.64 (+0.83%)

JNJ Johnson & Johnson
$145.30 /

+2.85 (+2.00%)

INO Inovio
$25.57 /

+2.21 (+9.46%)

GSK GlaxoSmithKline
$40.07 /

+0.16 (+0.40%)

BNTX BioNTech
$77.73 /

+7.315 (+10.39%)

SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SNY Sanofi
$50.96 /

+0.64 (+1.27%)

PFE Pfizer
$35.22 /

+1.38 (+4.08%)

NVAX Novavax
$104.46 /

+10.1 (+10.70%)

MRNA Moderna
$71.72 /

+9.15 (+14.62%)

MRK Merck
$77.38 /

+0.64 (+0.83%)

JNJ Johnson & Johnson
$145.30 /

+2.85 (+2.00%)

INO Inovio
$25.57 /

+2.21 (+9.46%)

GSK GlaxoSmithKline
$40.07 /

+0.16 (+0.40%)

BNTX BioNTech
$77.73 /

+7.315 (+10.39%)

SPY SPDR S&P 500 ETF Trust
$314.80 /

-2.81 (-0.88%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Recommendations
UBS reiterates Buy on GSK as FDA belantamab docs are out » 12:02
07/13/20
07/13
12:02
07/13/20
12:02
GSK

GlaxoSmithKline

$40.32 /

+0.415 (+1.04%)

UBS analyst Laura…

UBS analyst Laura Sutcliffe reiterated a Buy rating and GBp 1,920 price target on GlaxoSmithKline, saying that, on schedule, FDA documents for the belantamab ad com are out.

ShowHide Related Items >><<
GSK GlaxoSmithKline
$40.32 /

+0.415 (+1.04%)

GSK GlaxoSmithKline
$40.32 /

+0.415 (+1.04%)

07/13/20 JPMorgan
Ideaya upgraded to Overweight on recent pullback at JPMorgan
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/19/20 Barclays
Glaxo belantamab AdCom a surprise, supports cautious view, says Barclays
06/16/20 Roth Capital
Ideaya Biosciences price target raised to $23 from $12 at Roth Capital
GSK GlaxoSmithKline
$40.32 /

+0.415 (+1.04%)

GSK GlaxoSmithKline
$40.32 /

+0.415 (+1.04%)

GSK GlaxoSmithKline
$40.32 /

+0.415 (+1.04%)

GSK GlaxoSmithKline
$40.32 /

+0.415 (+1.04%)

Upgrade
Ideaya upgraded to Overweight on recent pullback at JPMorgan » 09:13
07/13/20
07/13
09:13
07/13/20
09:13
IDYA

Ideaya Biosciences

$13.30 /

-0.06 (-0.45%)

, GSK

GlaxoSmithKline

$39.91 /

-0.435 (-1.08%)

JPMorgan analyst Anupam…

JPMorgan analyst Anupam Rama upgraded Ideaya Biosciences (IDYA) to Overweight from Neutral with a price target of $28, up from $13. While the shares are up 78% year-to-date, they are down 30%-35% from highs following the GlaxoSmithKline (GSK) synthetic lethality partnership announcement in mid-June, Rama tells investors in a research note. The recent downside has created an "opportune entry point" into Ideaya shares, says the analyst. He believes the recent GSK partnership for the synthetic lethality pipeline provides external validation for several programs and that IDE196 in mutated tumors is underappreciated. Further, Ideaya has removed any need to finance in the near term, says Rama.

ShowHide Related Items >><<
IDYA Ideaya Biosciences
$13.30 /

-0.06 (-0.45%)

GSK GlaxoSmithKline
$39.91 /

-0.435 (-1.08%)

IDYA Ideaya Biosciences
$13.30 /

-0.06 (-0.45%)

07/13/20 JPMorgan
Ideaya Biosciences upgraded to Overweight from Neutral at JPMorgan
06/17/20 H.C. Wainwright
Ideaya Biosciences price target raised to $22 from $13 at H.C. Wainwright
06/16/20 Roth Capital
Ideaya Biosciences price target raised to $23 from $12 at Roth Capital
06/16/20 Oppenheimer
Ideaya Biosciences price target raised to $25 from $17 at Oppenheimer
GSK GlaxoSmithKline
$39.91 /

-0.435 (-1.08%)

06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/19/20 Barclays
Glaxo belantamab AdCom a surprise, supports cautious view, says Barclays
05/14/20 UBS
GlaxoSmithKline price target raised to 1,920 GBp from 1,900 GBp at UBS
IDYA Ideaya Biosciences
$13.30 /

-0.06 (-0.45%)

GSK GlaxoSmithKline
$39.91 /

-0.435 (-1.08%)

  • 18
    Jun
GSK GlaxoSmithKline
$39.91 /

-0.435 (-1.08%)

IDYA Ideaya Biosciences
$13.30 /

-0.06 (-0.45%)

GSK GlaxoSmithKline
$39.91 /

-0.435 (-1.08%)

IDYA Ideaya Biosciences
$13.30 /

-0.06 (-0.45%)

GSK GlaxoSmithKline
$39.91 /

-0.435 (-1.08%)

Friday
Hot Stocks
FDA concerned about ocular toxicity into meeting on GSK's belantamab » 10:05
07/10/20
07/10
10:05
07/10/20
10:05
GSK

GlaxoSmithKline

$39.96 /

-0.38 (-0.94%)

In briefing documents for…

In briefing documents for its July 14 meeting discussing GlaxoSmithKline's belantamab mafodotin, the FDA's Oncologic Drugs Advisory Committee said, "The concerns and uncertainties regarding the ocular toxicities raises questions about the overall benefit-risk profile of the belantamab mafodotin in the proposed patient population. The FDA seeks input from the committee on whether the demonstrated benefit of belantamab mafodotin outweighs the risks in the proposed patient population with multiple myeloma...Given the incomplete data regarding the reversibility of ocular toxicity, there is uncertainty at this time whether the dose modification strategy proposed by the Applicant is sufficient to mitigate the risk of ocular toxicity with belantamab mafodotin...Overall, considering the frequency and severity of ocular toxicity associated with belantamab mafodotin, the lack of clear mitigation strategies, and incomplete data regarding reversibility and severity, there is uncertainty whether the proposed dose modification strategy is sufficient to mitigate the risks. Although the efficacy results from DREAMM-2 suggest a benefit with belantamab mafodotin in the proposed population of patients with RRMM, it is not clear whether the benefit outweighs the risks of ocular toxicity." Shares of GlaxoSmithKline are down 1% to $39.79 in morning trading. Reference Link

ShowHide Related Items >><<
GSK GlaxoSmithKline
$39.96 /

-0.38 (-0.94%)

GSK GlaxoSmithKline
$39.96 /

-0.38 (-0.94%)

06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/19/20 Barclays
Glaxo belantamab AdCom a surprise, supports cautious view, says Barclays
06/16/20 Roth Capital
Ideaya Biosciences price target raised to $23 from $12 at Roth Capital
05/14/20 UBS
GlaxoSmithKline price target raised to 1,920 GBp from 1,900 GBp at UBS
GSK GlaxoSmithKline
$39.96 /

-0.38 (-0.94%)

GSK GlaxoSmithKline
$39.96 /

-0.38 (-0.94%)

GSK GlaxoSmithKline
$39.96 /

-0.38 (-0.94%)

GSK GlaxoSmithKline
$39.96 /

-0.38 (-0.94%)

Thursday
Hot Stocks
Pfizer pledges $100M to new Antimicrobial Resistance Action Fund » 15:23
07/09/20
07/09
15:23
07/09/20
15:23
PFE

Pfizer

$33.57 /

-0.19 (-0.56%)

, AMGN

Amgen

$252.34 /

+0.74 (+0.29%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, LLY

Eli Lilly

$166.59 /

-2.52 (-1.49%)

, GSK

GlaxoSmithKline

$40.37 /

-0.35 (-0.86%)

, MRK

Merck

$76.99 /

-0.88 (-1.13%)

, MKGAY

Merck KGaA

$0.00 /

+ (+0.00%)

, TEVA

Teva

$11.60 /

+0.21 (+1.84%)

, TAK

Takeda Pharmaceutical

$17.36 /

-0.135 (-0.77%)

, NVO

Novo Nordisk

$65.63 /

-0.23 (-0.35%)

, JNJ

Johnson & Johnson

$143.03 /

-0.21 (-0.15%)

, NVS

Novartis

$87.53 /

-0.585 (-0.66%)

Pfizer (PFE) announced…

Pfizer (PFE) announced earlier it has pledged $100M to the new Antimicrobial Resistance, or "AMR," Action Fund, which launched today, to help address the significant global public health need for new antibiotics due to the rapid rise of antibiotic-resistant infections. "The AMR Action Fund is a ground-breaking collaboration among more than 20 biopharmaceutical companies that aims to bring 2-4 new antibiotics to patients by 2030 through collaboration between pharmaceutical companies, philanthropies, development banks, and multilateral organizations to re-invigorate and accelerate antibiotic development," the company stated. "As the COVID-19 pandemic has shown, we must invest in the development of medicines now so that we are prepared to help prevent the next public health crisis," added Pfizer Chairman and CEO Albert Bourla. Other investors in the AMR Action Fund include Amgen (AMGN), Bayer (BAYRY), Roche (RHHBY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Merck (MRK), Merck KGaA (MKGAY), Teva (TEVA), Takeda Pharmaceutical (TAK), Novo Nordisk (NVO), Johnson & Johnson (JNJ) and Novartis (NVS). Reference Link

ShowHide Related Items >><<
TEVA Teva
$11.60 /

+0.21 (+1.84%)

TAK Takeda Pharmaceutical
$17.36 /

-0.135 (-0.77%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$33.57 /

-0.19 (-0.56%)

NVS Novartis
$87.53 /

-0.585 (-0.66%)

NVO Novo Nordisk
$65.63 /

-0.23 (-0.35%)

MRK Merck
$76.99 /

-0.88 (-1.13%)

MKGAY Merck KGaA
$0.00 /

+ (+0.00%)

LLY Eli Lilly
$166.59 /

-2.52 (-1.49%)

JNJ Johnson & Johnson
$143.03 /

-0.21 (-0.15%)

GSK GlaxoSmithKline
$40.37 /

-0.35 (-0.86%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AMGN Amgen
$252.34 /

+0.74 (+0.29%)

PFE Pfizer
$33.57 /

-0.19 (-0.56%)

07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
AMGN Amgen
$252.34 /

+0.74 (+0.29%)

07/02/20 Citi
Citi sees 'considerable amount of investor interest' coming back to Amgen
07/01/20 Piper Sandler
Amgen appeal rules in favor of patent validity, says Piper Sandler
07/01/20 Mizuho
Amgen patent win worth $5-$12 per share, says Mizuho
07/01/20 Goldman Sachs
Court ruling removes overhang for Amgen, says Goldman Sachs
BAYRY Bayer
$0.00 /

+ (+0.00%)

06/26/20 JPMorgan
Bayer price target raised to EUR 77 from EUR 75 at JPMorgan
06/26/20 Deutsche Bank
Bayer price target raised to EUR 87 from EUR 85 at Deutsche Bank
06/25/20 Morgan Stanley
Bayer price target raised to EUR 88 from EUR 83 at Morgan Stanley
06/25/20 HSBC
HSBC upgrades Bayer to Buy after settlement on most Monsanto cases in U.S.
RHHBY Roche
$0.00 /

+ (+0.00%)

07/03/20 AlphaValue
Roche upgraded to Add from Reduce at AlphaValue
06/29/20 Piper Sandler
Herceptin/Perjecta approval another win for Halozyme, says Piper
06/23/20 Guggenheim
Immunomedics could be M&A fit for several large-cap drugmakers, says Guggenheim
06/10/20 SunTrust
Arcus Biosciences price target raised to $45 from $22 at SunTrust
LLY Eli Lilly
$166.59 /

-2.52 (-1.49%)

07/09/20 Morgan Stanley
Eli Lilly won't publish Phase 1 COVID antibody data, says Morgan Stanley
06/29/20 Mizuho
Eli Lilly price target raised to $164 from $155 at Mizuho
06/17/20 JPMorgan
Eli Lilly price target raised to $190 from $175 at JPMorgan
GSK GlaxoSmithKline
$40.37 /

-0.35 (-0.86%)

06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/19/20 Barclays
Glaxo belantamab AdCom a surprise, supports cautious view, says Barclays
06/16/20 Roth Capital
Ideaya Biosciences price target raised to $23 from $12 at Roth Capital
05/14/20 UBS
GlaxoSmithKline price target raised to 1,920 GBp from 1,900 GBp at UBS
MRK Merck
$76.99 /

-0.88 (-1.13%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
MKGAY Merck KGaA
$0.00 /

+ (+0.00%)

05/15/20 Nord/LB
Merck KGaA downgraded to Hold from Buy at Nord/LB
03/06/20 UBS
UBS backs Neutral on Merck KGaA after Q4 results
12/02/19 Goldman Sachs
Merck KGaA reinstated with a Sell at Goldman Sachs
10/04/19 Loop Capital
Entegris price target raised to $51 from $47 at Loop Capital
TEVA Teva
$11.60 /

+0.21 (+1.84%)

07/02/20 Wells Fargo
Emergent BioSolutions price target raised to $93 from $85 at Wells Fargo
06/26/20 William Blair
Pfenex partner CHMP opinion 'material de-risking event,' says William Blair
06/17/20 Stifel
Amarin settlement with Apotex an 'incremental positive,' says Stifel
06/08/20 Guggenheim
Emergent BioSolutions price target lowered to $87 from $101 at Guggenheim
TAK Takeda Pharmaceutical
$17.36 /

-0.135 (-0.77%)

06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
06/17/20 Oppenheimer
Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer
04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
NVO Novo Nordisk
$65.63 /

-0.23 (-0.35%)

07/06/20 BofA
Novo Nordisk downgraded to Neutral from Buy at BofA
06/05/20 JPMorgan
JPMorgan backs Overweight on Novo Nordisk after STEP data
05/18/20 Morgan Stanley
Novo Nordisk price target raised to DKK 435 from DKK 425 at Morgan Stanley
05/13/20 JPMorgan
Novo Nordisk price target raised to DKK 480 from DKK 460 at JPMorgan
JNJ Johnson & Johnson
$143.03 /

-0.21 (-0.15%)

07/06/20 Baird
Cooper Companies downgraded to Neutral, Baird see confluence of issues
07/01/20 JMP Securities
Minerva's seltorexant still 'underappreciated' upside driver, says JMP
05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
NVS Novartis
$87.53 /

-0.585 (-0.66%)

07/01/20 Jefferies
Amgen win on Enbrel patent removes key overhang, says Jefferies
07/01/20 Goldman Sachs
Global Blood Therapeutics upgraded to Buy from Neutral at Goldman Sachs
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
TEVA Teva
$11.60 /

+0.21 (+1.84%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$33.57 /

-0.19 (-0.56%)

NVS Novartis
$87.53 /

-0.585 (-0.66%)

NVO Novo Nordisk
$65.63 /

-0.23 (-0.35%)

MRK Merck
$76.99 /

-0.88 (-1.13%)

LLY Eli Lilly
$166.59 /

-2.52 (-1.49%)

JNJ Johnson & Johnson
$143.03 /

-0.21 (-0.15%)

GSK GlaxoSmithKline
$40.37 /

-0.35 (-0.86%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AMGN Amgen
$252.34 /

+0.74 (+0.29%)

TEVA Teva
$11.60 /

+0.21 (+1.84%)

TAK Takeda Pharmaceutical
$17.36 /

-0.135 (-0.77%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$33.57 /

-0.19 (-0.56%)

NVO Novo Nordisk
$65.63 /

-0.23 (-0.35%)

MRK Merck
$76.99 /

-0.88 (-1.13%)

MKGAY Merck KGaA
$0.00 /

+ (+0.00%)

LLY Eli Lilly
$166.59 /

-2.52 (-1.49%)

JNJ Johnson & Johnson
$143.03 /

-0.21 (-0.15%)

GSK GlaxoSmithKline
$40.37 /

-0.35 (-0.86%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AMGN Amgen
$252.34 /

+0.74 (+0.29%)

TEVA Teva
$11.60 /

+0.21 (+1.84%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$33.57 /

-0.19 (-0.56%)

NVS Novartis
$87.53 /

-0.585 (-0.66%)

NVO Novo Nordisk
$65.63 /

-0.23 (-0.35%)

MRK Merck
$76.99 /

-0.88 (-1.13%)

LLY Eli Lilly
$166.59 /

-2.52 (-1.49%)

JNJ Johnson & Johnson
$143.03 /

-0.21 (-0.15%)

GSK GlaxoSmithKline
$40.37 /

-0.35 (-0.86%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AMGN Amgen
$252.34 /

+0.74 (+0.29%)

TEVA Teva
$11.60 /

+0.21 (+1.84%)

TAK Takeda Pharmaceutical
$17.36 /

-0.135 (-0.77%)

PFE Pfizer
$33.57 /

-0.19 (-0.56%)

NVS Novartis
$87.53 /

-0.585 (-0.66%)

MRK Merck
$76.99 /

-0.88 (-1.13%)

LLY Eli Lilly
$166.59 /

-2.52 (-1.49%)

JNJ Johnson & Johnson
$143.03 /

-0.21 (-0.15%)

GSK GlaxoSmithKline
$40.37 /

-0.35 (-0.86%)

AMGN Amgen
$252.34 /

+0.74 (+0.29%)

Conference/Events
Oxford Global Marketing to hold a virtual event » 04:55
07/09/20
07/09
04:55
07/09/20
04:55
ABBV

AbbVie

$99.28 /

-0.06 (-0.06%)

, AZN

AstraZeneca

$54.19 /

+0.7 (+1.31%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BMY

Bristol-Myers

$59.58 /

-0.72 (-1.19%)

, GSK

GlaxoSmithKline

$40.72 /

+0.34 (+0.84%)

, IPSEY

Ipsen

$0.00 /

+ (+0.00%)

, JAZZ

Jazz Pharmaceuticals

$107.54 /

-1.18 (-1.09%)

, JNJ

Johnson & Johnson

$143.24 /

+0.43 (+0.30%)

, NVS

Novartis

$88.12 /

+0.345 (+0.39%)

, PFE

Pfizer

$33.76 /

-0.27 (-0.79%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, RTRX

Retrophin

$20.86 /

-0.04 (-0.19%)

, SNY

Sanofi

$51.54 /

+0.14 (+0.27%)

, TAK

Takeda Pharmaceutical

$17.49 /

+0.01 (+0.06%)

, TEVA

Teva

$11.39 /

+0.17 (+1.52%)

Formulation &…

Formulation & Delivery Series Biomanufacturing Virtual Congress will be held on July 8-9. Webcast Link

ShowHide Related Items >><<
TEVA Teva
$11.39 /

+0.17 (+1.52%)

TAK Takeda Pharmaceutical
$17.49 /

+0.01 (+0.06%)

SNY Sanofi
$51.54 /

+0.14 (+0.27%)

RTRX Retrophin
$20.86 /

-0.04 (-0.19%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$33.76 /

-0.27 (-0.79%)

NVS Novartis
$88.12 /

+0.345 (+0.39%)

JNJ Johnson & Johnson
$143.24 /

+0.43 (+0.30%)

JAZZ Jazz Pharmaceuticals
$107.54 /

-1.18 (-1.09%)

IPSEY Ipsen
$0.00 /

+ (+0.00%)

GSK GlaxoSmithKline
$40.72 /

+0.34 (+0.84%)

BMY Bristol-Myers
$59.58 /

-0.72 (-1.19%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

07/07/20 SunTrust
Evolus price target lowered to $6 from $12 at SunTrust
07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/29/20 Mizuho
AbbVie price target raised to $110 from $101 at Mizuho
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

06/24/20 Oddo BHF
AstraZeneca downgraded to Reduce from Buy at Oddo BHF
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/10/20 Cowen
AstraZeneca price target raised to $60 from $55 at Cowen
06/10/20 Guggenheim
Merck's bladder cancer failure boosts strategic value of Padcev, says Guggenheim
BAYRY Bayer
$0.00 /

+ (+0.00%)

06/26/20 JPMorgan
Bayer price target raised to EUR 77 from EUR 75 at JPMorgan
06/26/20 Deutsche Bank
Bayer price target raised to EUR 87 from EUR 85 at Deutsche Bank
06/25/20 Morgan Stanley
Bayer price target raised to EUR 88 from EUR 83 at Morgan Stanley
06/25/20 HSBC
HSBC upgrades Bayer to Buy after settlement on most Monsanto cases in U.S.
BMY Bristol-Myers
$59.58 /

-0.72 (-1.19%)

06/22/20 Morgan Stanley
Morgan Stanley sees Eliquis patent being upheld, ruling being 'imminent'
06/08/20 Bernstein
Gilead, AstraZeneca merger would make sense on economic basis, says Bernstein
06/02/20 Credit Suisse
Arena Pharmaceuticals price target raised to $87 from $77 at Credit Suisse
06/02/20 Cantor Fitzgerald
Arena Pharmaceuticals price target raised to $88 from $68 at Cantor Fitzgerald
GSK GlaxoSmithKline
$40.72 /

+0.34 (+0.84%)

06/19/20 Barclays
Glaxo belantamab AdCom a surprise, supports cautious view, says Barclays
06/16/20 Roth Capital
Ideaya Biosciences price target raised to $23 from $12 at Roth Capital
05/14/20 UBS
GlaxoSmithKline price target raised to 1,920 GBp from 1,900 GBp at UBS
IPSEY Ipsen
$0.00 /

+ (+0.00%)

06/08/20 Bryan Garnier
Ipsen upgraded to Buy from Neutral at Bryan Garnier
06/01/20 Barclays
Ipsen price target raised to EUR 72 from EUR 62 at Barclays
06/01/20 BofA
Ipsen upgraded to Buy from Neutral at BofA
05/18/20 JPMorgan
Ipsen upgraded to Neutral on Cabometyx potential at JPMorgan
JAZZ Jazz Pharmaceuticals
$107.54 /

-1.18 (-1.09%)

06/23/20 Barclays
Jazz Pharmaceuticals price target raised to $195 from $183 at Barclays
06/01/20 SVB Leerink
Jazz Pharmaceuticals price target raised to $169 from $160 at SVB Leerink
05/06/20 SVB Leerink
Jazz Pharmaceuticals price target lowered to $160 from $169 at SVB Leerink
05/06/20 Oppenheimer
Jazz Pharmaceuticals price target lowered to $132 from $141 at Oppenheimer
JNJ Johnson & Johnson
$143.24 /

+0.43 (+0.30%)

07/06/20 Baird
Cooper Companies downgraded to Neutral, Baird see confluence of issues
07/01/20 JMP Securities
Minerva's seltorexant still 'underappreciated' upside driver, says JMP
05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
NVS Novartis
$88.12 /

+0.345 (+0.39%)

07/01/20 Piper Sandler
Amgen appeal rules in favor of patent validity, says Piper Sandler
07/01/20 Jefferies
Amgen win on Enbrel patent removes key overhang, says Jefferies
07/01/20 Goldman Sachs
Global Blood Therapeutics upgraded to Buy from Neutral at Goldman Sachs
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
PFE Pfizer
$33.76 /

-0.27 (-0.79%)

07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
RHHBY Roche
$0.00 /

+ (+0.00%)

07/03/20 AlphaValue
Roche upgraded to Add from Reduce at AlphaValue
06/29/20 Piper Sandler
Herceptin/Perjecta approval another win for Halozyme, says Piper
06/23/20 Guggenheim
Immunomedics could be M&A fit for several large-cap drugmakers, says Guggenheim
06/10/20 SunTrust
Arcus Biosciences price target raised to $45 from $22 at SunTrust
RTRX Retrophin
$20.86 /

-0.04 (-0.19%)

06/16/20 BTIG
Retrophin initiated with a Buy at BTIG
02/25/20 Barclays
Retrophin downgraded to Equal Weight from Overweight at Barclays
01/13/20 JMP Securities
JMP says continues to like Retrophin opportunity
08/23/19 BMO Capital
Retrophin price target lowered to $33 from $38 at BMO Capital
SNY Sanofi
$51.54 /

+0.14 (+0.27%)

07/08/20 Piper Sandler
Piper upgrades Kiadis on 'platform validating' Sanofi deal
07/06/20 Citi
BioMarin price target raised to $148 from $105 at Citi
07/01/20 Roth Capital
Applied Genetic may attract Sanofi takeover interest, says Roth Capital
06/26/20 SunTrust
Translate Bio initiated with a Buy at SunTrust
TAK Takeda Pharmaceutical
$17.49 /

+0.01 (+0.06%)

06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
06/17/20 Oppenheimer
Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer
04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
TEVA Teva
$11.39 /

+0.17 (+1.52%)

07/02/20 Wells Fargo
Emergent BioSolutions price target raised to $93 from $85 at Wells Fargo
06/26/20 William Blair
Pfenex partner CHMP opinion 'material de-risking event,' says William Blair
06/17/20 Stifel
Amarin settlement with Apotex an 'incremental positive,' says Stifel
06/08/20 Guggenheim
Emergent BioSolutions price target lowered to $87 from $101 at Guggenheim
TEVA Teva
$11.39 /

+0.17 (+1.52%)

SNY Sanofi
$51.54 /

+0.14 (+0.27%)

RTRX Retrophin
$20.86 /

-0.04 (-0.19%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$33.76 /

-0.27 (-0.79%)

NVS Novartis
$88.12 /

+0.345 (+0.39%)

JNJ Johnson & Johnson
$143.24 /

+0.43 (+0.30%)

JAZZ Jazz Pharmaceuticals
$107.54 /

-1.18 (-1.09%)

GSK GlaxoSmithKline
$40.72 /

+0.34 (+0.84%)

BMY Bristol-Myers
$59.58 /

-0.72 (-1.19%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

  • 09
    Jun
TEVA Teva
$11.39 /

+0.17 (+1.52%)

TAK Takeda Pharmaceutical
$17.49 /

+0.01 (+0.06%)

SNY Sanofi
$51.54 /

+0.14 (+0.27%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$33.76 /

-0.27 (-0.79%)

NVS Novartis
$88.12 /

+0.345 (+0.39%)

JNJ Johnson & Johnson
$143.24 /

+0.43 (+0.30%)

GSK GlaxoSmithKline
$40.72 /

+0.34 (+0.84%)

BMY Bristol-Myers
$59.58 /

-0.72 (-1.19%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

TEVA Teva
$11.39 /

+0.17 (+1.52%)

SNY Sanofi
$51.54 /

+0.14 (+0.27%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$33.76 /

-0.27 (-0.79%)

NVS Novartis
$88.12 /

+0.345 (+0.39%)

JNJ Johnson & Johnson
$143.24 /

+0.43 (+0.30%)

JAZZ Jazz Pharmaceuticals
$107.54 /

-1.18 (-1.09%)

IPSEY Ipsen
$0.00 /

+ (+0.00%)

GSK GlaxoSmithKline
$40.72 /

+0.34 (+0.84%)

BMY Bristol-Myers
$59.58 /

-0.72 (-1.19%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

TEVA Teva
$11.39 /

+0.17 (+1.52%)

TAK Takeda Pharmaceutical
$17.49 /

+0.01 (+0.06%)

SNY Sanofi
$51.54 /

+0.14 (+0.27%)

PFE Pfizer
$33.76 /

-0.27 (-0.79%)

NVS Novartis
$88.12 /

+0.345 (+0.39%)

JNJ Johnson & Johnson
$143.24 /

+0.43 (+0.30%)

GSK GlaxoSmithKline
$40.72 /

+0.34 (+0.84%)

BMY Bristol-Myers
$59.58 /

-0.72 (-1.19%)

AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

Wednesday
Conference/Events
Oxford Global Marketing to hold a virtual event » 09:24
07/08/20
07/08
09:24
07/08/20
09:24
ABBV

AbbVie

$99.34 /

+0.31 (+0.31%)

, AZN

AstraZeneca

$53.49 /

-0.61 (-1.13%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BMY

Bristol-Myers

$60.30 /

+0.09 (+0.15%)

, GSK

GlaxoSmithKline

$40.38 /

-0.625 (-1.52%)

, IPSEY

Ipsen

$0.00 /

+ (+0.00%)

, JAZZ

Jazz Pharmaceuticals

$108.72 /

-2.48 (-2.23%)

, JNJ

Johnson & Johnson

$142.81 /

-0.18 (-0.13%)

, NVS

Novartis

$87.77 /

-0.65 (-0.74%)

, PFE

Pfizer

$34.03 /

-0.48 (-1.39%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, RTRX

Retrophin

$20.90 /

+0.34 (+1.65%)

, SNY

Sanofi

$51.40 /

-0.78 (-1.49%)

, TAK

Takeda Pharmaceutical

$17.48 /

-0.18 (-1.02%)

, TEVA

Teva

$11.22 /

-0.31 (-2.69%)

Formulation &…

Formulation & Delivery Series Biomanufacturing Virtual Congress will be held on July 8-9. Webcast Link

ShowHide Related Items >><<
TEVA Teva
$11.22 /

-0.31 (-2.69%)

TAK Takeda Pharmaceutical
$17.48 /

-0.18 (-1.02%)

SNY Sanofi
$51.40 /

-0.78 (-1.49%)

RTRX Retrophin
$20.90 /

+0.34 (+1.65%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$34.03 /

-0.48 (-1.39%)

NVS Novartis
$87.77 /

-0.65 (-0.74%)

JNJ Johnson & Johnson
$142.81 /

-0.18 (-0.13%)

JAZZ Jazz Pharmaceuticals
$108.72 /

-2.48 (-2.23%)

IPSEY Ipsen
$0.00 /

+ (+0.00%)

GSK GlaxoSmithKline
$40.38 /

-0.625 (-1.52%)

BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$53.49 /

-0.61 (-1.13%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

07/07/20 SunTrust
Evolus price target lowered to $6 from $12 at SunTrust
07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/29/20 Mizuho
AbbVie price target raised to $110 from $101 at Mizuho
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
AZN AstraZeneca
$53.49 /

-0.61 (-1.13%)

06/24/20 Oddo BHF
AstraZeneca downgraded to Reduce from Buy at Oddo BHF
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/10/20 Cowen
AstraZeneca price target raised to $60 from $55 at Cowen
06/10/20 Guggenheim
Merck's bladder cancer failure boosts strategic value of Padcev, says Guggenheim
BAYRY Bayer
$0.00 /

+ (+0.00%)

06/26/20 JPMorgan
Bayer price target raised to EUR 77 from EUR 75 at JPMorgan
06/26/20 Deutsche Bank
Bayer price target raised to EUR 87 from EUR 85 at Deutsche Bank
06/25/20 Morgan Stanley
Bayer price target raised to EUR 88 from EUR 83 at Morgan Stanley
06/25/20 HSBC
HSBC upgrades Bayer to Buy after settlement on most Monsanto cases in U.S.
BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

06/22/20 Morgan Stanley
Morgan Stanley sees Eliquis patent being upheld, ruling being 'imminent'
06/08/20 Bernstein
Gilead, AstraZeneca merger would make sense on economic basis, says Bernstein
06/02/20 Credit Suisse
Arena Pharmaceuticals price target raised to $87 from $77 at Credit Suisse
06/02/20 Cantor Fitzgerald
Arena Pharmaceuticals price target raised to $88 from $68 at Cantor Fitzgerald
GSK GlaxoSmithKline
$40.38 /

-0.625 (-1.52%)

06/19/20 Barclays
Glaxo belantamab AdCom a surprise, supports cautious view, says Barclays
06/16/20 Roth Capital
Ideaya Biosciences price target raised to $23 from $12 at Roth Capital
05/14/20 UBS
GlaxoSmithKline price target raised to 1,920 GBp from 1,900 GBp at UBS
IPSEY Ipsen
$0.00 /

+ (+0.00%)

06/08/20 Bryan Garnier
Ipsen upgraded to Buy from Neutral at Bryan Garnier
06/01/20 Barclays
Ipsen price target raised to EUR 72 from EUR 62 at Barclays
06/01/20 BofA
Ipsen upgraded to Buy from Neutral at BofA
05/18/20 JPMorgan
Ipsen upgraded to Neutral on Cabometyx potential at JPMorgan
JAZZ Jazz Pharmaceuticals
$108.72 /

-2.48 (-2.23%)

06/23/20 Barclays
Jazz Pharmaceuticals price target raised to $195 from $183 at Barclays
06/01/20 SVB Leerink
Jazz Pharmaceuticals price target raised to $169 from $160 at SVB Leerink
05/06/20 SVB Leerink
Jazz Pharmaceuticals price target lowered to $160 from $169 at SVB Leerink
05/06/20 Oppenheimer
Jazz Pharmaceuticals price target lowered to $132 from $141 at Oppenheimer
JNJ Johnson & Johnson
$142.81 /

-0.18 (-0.13%)

07/06/20 Baird
Cooper Companies downgraded to Neutral, Baird see confluence of issues
07/01/20 JMP Securities
Minerva's seltorexant still 'underappreciated' upside driver, says JMP
05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
NVS Novartis
$87.77 /

-0.65 (-0.74%)

07/01/20 Piper Sandler
Amgen appeal rules in favor of patent validity, says Piper Sandler
07/01/20 Jefferies
Amgen win on Enbrel patent removes key overhang, says Jefferies
07/01/20 Goldman Sachs
Global Blood Therapeutics upgraded to Buy from Neutral at Goldman Sachs
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
PFE Pfizer
$34.03 /

-0.48 (-1.39%)

07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
07/02/20 BMO Capital
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital
RHHBY Roche
$0.00 /

+ (+0.00%)

07/03/20 AlphaValue
Roche upgraded to Add from Reduce at AlphaValue
06/29/20 Piper Sandler
Herceptin/Perjecta approval another win for Halozyme, says Piper
06/23/20 Guggenheim
Immunomedics could be M&A fit for several large-cap drugmakers, says Guggenheim
06/10/20 SunTrust
Arcus Biosciences price target raised to $45 from $22 at SunTrust
RTRX Retrophin
$20.90 /

+0.34 (+1.65%)

06/16/20 BTIG
Retrophin initiated with a Buy at BTIG
02/25/20 Barclays
Retrophin downgraded to Equal Weight from Overweight at Barclays
01/13/20 JMP Securities
JMP says continues to like Retrophin opportunity
08/23/19 BMO Capital
Retrophin price target lowered to $33 from $38 at BMO Capital
SNY Sanofi
$51.40 /

-0.78 (-1.49%)

07/06/20 Citi
BioMarin price target raised to $148 from $105 at Citi
07/01/20 Roth Capital
Applied Genetic may attract Sanofi takeover interest, says Roth Capital
06/26/20 SunTrust
Translate Bio initiated with a Buy at SunTrust
06/24/20 Roth Capital
Translate Bio price target raised to $30 from $25 at Roth Capital
TAK Takeda Pharmaceutical
$17.48 /

-0.18 (-1.02%)

06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
06/17/20 Oppenheimer
Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer
04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
TEVA Teva
$11.22 /

-0.31 (-2.69%)

07/02/20 Wells Fargo
Emergent BioSolutions price target raised to $93 from $85 at Wells Fargo
06/26/20 William Blair
Pfenex partner CHMP opinion 'material de-risking event,' says William Blair
06/17/20 Stifel
Amarin settlement with Apotex an 'incremental positive,' says Stifel
06/08/20 Guggenheim
Emergent BioSolutions price target lowered to $87 from $101 at Guggenheim
TEVA Teva
$11.22 /

-0.31 (-2.69%)

SNY Sanofi
$51.40 /

-0.78 (-1.49%)

RTRX Retrophin
$20.90 /

+0.34 (+1.65%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$34.03 /

-0.48 (-1.39%)

NVS Novartis
$87.77 /

-0.65 (-0.74%)

JNJ Johnson & Johnson
$142.81 /

-0.18 (-0.13%)

JAZZ Jazz Pharmaceuticals
$108.72 /

-2.48 (-2.23%)

GSK GlaxoSmithKline
$40.38 /

-0.625 (-1.52%)

BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$53.49 /

-0.61 (-1.13%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

  • 09
    Jun
TEVA Teva
$11.22 /

-0.31 (-2.69%)

TAK Takeda Pharmaceutical
$17.48 /

-0.18 (-1.02%)

SNY Sanofi
$51.40 /

-0.78 (-1.49%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$34.03 /

-0.48 (-1.39%)

NVS Novartis
$87.77 /

-0.65 (-0.74%)

JNJ Johnson & Johnson
$142.81 /

-0.18 (-0.13%)

GSK GlaxoSmithKline
$40.38 /

-0.625 (-1.52%)

BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$53.49 /

-0.61 (-1.13%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

TEVA Teva
$11.22 /

-0.31 (-2.69%)

SNY Sanofi
$51.40 /

-0.78 (-1.49%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$34.03 /

-0.48 (-1.39%)

NVS Novartis
$87.77 /

-0.65 (-0.74%)

JNJ Johnson & Johnson
$142.81 /

-0.18 (-0.13%)

JAZZ Jazz Pharmaceuticals
$108.72 /

-2.48 (-2.23%)

IPSEY Ipsen
$0.00 /

+ (+0.00%)

GSK GlaxoSmithKline
$40.38 /

-0.625 (-1.52%)

BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$53.49 /

-0.61 (-1.13%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

TEVA Teva
$11.22 /

-0.31 (-2.69%)

TAK Takeda Pharmaceutical
$17.48 /

-0.18 (-1.02%)

SNY Sanofi
$51.40 /

-0.78 (-1.49%)

PFE Pfizer
$34.03 /

-0.48 (-1.39%)

NVS Novartis
$87.77 /

-0.65 (-0.74%)

JNJ Johnson & Johnson
$142.81 /

-0.18 (-0.13%)

GSK GlaxoSmithKline
$40.38 /

-0.625 (-1.52%)

BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

AZN AstraZeneca
$53.49 /

-0.61 (-1.13%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

Over a week ago
On The Fly
Fly Intel: Wall Street's top stories for Tuesday » 16:42
07/07/20
07/07
16:42
07/07/20
16:42
NVAX

Novavax

$104.58 /

+25.23 (+31.80%)

, REGN

Regeneron

$639.90 /

+13.25 (+2.11%)

, SHAK

Shake Shack

$49.85 /

-3.53 (-6.61%)

, AMZN

Amazon.com

$3,004.68 /

-53.01 (-1.73%)

, SIRI

Sirius XM

$5.78 /

-0.07 (-1.20%)

, SSP

E.W. Scripps

$8.68 /

+0.28 (+3.33%)

, SPOT

Spotify

$262.11 /

+2.035 (+0.78%)

, IHRT

iHeartMedia

$7.11 /

-0.02 (-0.28%)

, RUN

Sunrun

$26.17 /

+4.825 (+22.60%)

, VSLR

Vivint Solar

$14.68 /

+4.05 (+38.10%)

, HRL

Hormel Foods

$48.15 /

+0.16 (+0.33%)

, PPC

Pilgrim's Pride

$16.41 /

-0.345 (-2.06%)

, SAFM

Sanderson Farms

$113.83 /

+0.56 (+0.49%)

, TSN

Tyson Foods

$58.66 /

-0.765 (-1.29%)

, LVGO

Livongo Health

$93.76 /

+16.19 (+20.87%)

, MXL

MaxLinear

$25.30 /

+3.41 (+15.58%)

, EOLS

Evolus

$3.86 /

-1.47 (-27.58%)

, ABBV

AbbVie

$99.34 /

+0.31 (+0.31%)

, COMM

CommScope

$7.95 /

-0.73 (-8.41%)

The S&P was little…

Open Full Text

ShowHide Related Items >><<
VSLR Vivint Solar
$14.68 /

+4.05 (+38.10%)

TSN Tyson Foods
$58.66 /

-0.765 (-1.29%)

SSP E.W. Scripps
$8.68 /

+0.28 (+3.33%)

SPOT Spotify
$262.11 /

+2.035 (+0.78%)

SIRI Sirius XM
$5.78 /

-0.07 (-1.20%)

SHAK Shake Shack
$49.85 /

-3.53 (-6.61%)

SAFM Sanderson Farms
$113.83 /

+0.56 (+0.49%)

RUN Sunrun
$26.17 /

+4.825 (+22.60%)

REGN Regeneron
$639.90 /

+13.25 (+2.11%)

PPC Pilgrim's Pride
$16.41 /

-0.345 (-2.06%)

NVAX Novavax
$104.58 /

+25.23 (+31.80%)

MXL MaxLinear
$25.30 /

+3.41 (+15.58%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

IHRT iHeartMedia
$7.11 /

-0.02 (-0.28%)

HRL Hormel Foods
$48.15 /

+0.16 (+0.33%)

EOLS Evolus
$3.86 /

-1.47 (-27.58%)

COMM CommScope
$7.95 /

-0.73 (-8.41%)

AMZN Amazon.com
$3,004.68 /

-53.01 (-1.73%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

NVAX Novavax
$104.58 /

+25.23 (+31.80%)

07/08/20 Ladenburg
Novavax downgraded to Neutral from Buy at Ladenburg
07/07/20 Cantor Fitzgerald
Novavax price target raised to $148 from $88 at Cantor Fitzgerald
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
06/29/20 B. Riley FBR
Novavax price target raised to $106 from $74 at B. Riley FBR
REGN Regeneron
$639.90 /

+13.25 (+2.11%)

07/01/20 Oppenheimer
Regeneron price target raised to $675 from $625 at Oppenheimer
06/24/20 Credit Suisse
Regeneron price target raised to $700 from $605 at Credit Suisse
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
06/18/20 Piper Sandler
AbbVie atopic dermatitis data a postive, says Piper Sandler
SHAK Shake Shack
$49.85 /

-3.53 (-6.61%)

06/24/20 JPMorgan
Shake Shack price target raised to $51 from $47 at JPMorgan
05/06/20 Deutsche Bank
Shake Shack price target raised to $57 from $51 at Deutsche Bank
05/05/20 MKM Partners
Shake Shack price target raised to $59 from $50 at MKM Partners
05/05/20 SunTrust
Shake Shack price target raised to $55 from $50 at SunTrust
AMZN Amazon.com
$3,004.68 /

-53.01 (-1.73%)

07/07/20 Baird
Amazon.com price target raised to $3,300 from $2,750 at Baird
07/07/20 Baird
Wayfair price target raised to $225 from $190 at Baird
06/30/20 Mizuho
Amazon.com price target raised to $3,100 from $2,550 at Mizuho
06/29/20 Monness Crespi
Amazon.com price target raised to $3,500 from $2,800 at Monness Crespi
SIRI Sirius XM
$5.78 /

-0.07 (-1.20%)

07/07/20
Stitcher would help Sirius 'future-proof' business, says B. Riley FBR
06/23/20 B. Riley FBR
Sirius XM estimate raises could drive stock 're-rating,' says B. Riley FBR
06/02/20 JPMorgan
Sirius XM named a top pick for June at JPMorgan
05/19/20 Pivotal Research
Liberty SiriusXM price target lowered to $52 from $63 at Pivotal Research
SSP E.W. Scripps
$8.68 /

+0.28 (+3.33%)

06/25/20 Benchmark
Benchmark sees material benefits if E.W. Scripps sells Stitcher
03/03/20 Wells Fargo
Disney price target lowered to $155 from $180 at Wells Fargo
12/11/19 Guggenheim
Guggenheim says Nexstar, Gray best positioned for 'record' political cycle
SPOT Spotify
$262.11 /

+2.035 (+0.78%)

07/06/20
Fly Intel: Top five analyst downgrades
07/06/20 JPMorgan
Spotify price target raised to $305 from $185 at JPMorgan
07/06/20 Bernstein
Bernstein doubts Spotify will make money off podcasts, downgrades to sell
07/06/20 Bernstein
Spotify downgraded to Underperform from Market Perform at Bernstein
IHRT iHeartMedia
$7.11 /

-0.02 (-0.28%)

07/01/20
Fly Intel: Top five analyst downgrades
07/01/20 BofA
iHeartMedia downgraded to Neutral from Buy at BofA
07/01/20 BofA
iHeartMedia downgraded to Neutral from Buy at BofA
04/23/20 Guggenheim
iHeartMedia price target lowered to $10 from $21.50 at Guggenheim
RUN Sunrun
$26.17 /

+4.825 (+22.60%)

07/07/20 JPMorgan
Sunrun price target raised to $30 from $24 at JPMorgan
07/07/20 JMP Securities
Vivint Solar downgraded to Market Perform from Outperform at JMP Securities
07/06/20 JMP Securities
Sunrun price target raised to $31 from $19 at JMP Securities
06/15/20 Credit Suisse
Sunrun price target raised to $29 from $18 at Credit Suisse
VSLR Vivint Solar
$14.68 /

+4.05 (+38.10%)

06/24/20 Goldman Sachs
Vivint Solar downgraded to Neutral from Buy at Goldman Sachs
06/05/20 JMP Securities
Vivint Solar price target raised to $15 from $10 at JMP Securities
06/02/20 Roth Capital
Roth says loan securitizations reopening a positive for residential solar names
HRL Hormel Foods
$48.15 /

+0.16 (+0.33%)

04/29/20
Fly Intel: Top five analyst downgrades
04/29/20 Piper Sandler
Hormel downgraded to Neutral on foodservice risk at Piper Sandler
04/28/20 Piper Sandler
Hormel Foods downgraded to Neutral from Overweight at Piper Sandler
03/26/20
Fly Intel: Top five analyst upgrades
PPC Pilgrim's Pride
$16.41 /

-0.345 (-2.06%)

06/29/20
Fly Intel: Top five analyst downgrades
06/29/20 BMO Capital
Pilgrim's Pride downgraded to Market Perform from Outperform at BMO Capital
06/29/20 BMO Capital
Pilgrim's Pride downgraded to Market Perform from Outperform at BMO Capital
06/29/20 Barclays
Pilgrim's Pride downgraded to Equal Weight from Overweight at Barclays
SAFM Sanderson Farms
$113.83 /

+0.56 (+0.49%)

06/04/20 BofA
BofA cuts Pilgrim's Pride, Sanderson Farms targets after price fixing indictment
06/03/20 Stephens
Stephens downgrades Pilgrim's Pride after indictment, suspends targets on peers
05/11/20 Stephens
Sanderson Farms price target raised to $150 from $110 at Stephens
04/03/20 Credit Suisse
Sanderson Farms price target lowered to $135 from $160 at Credit Suisse
TSN Tyson Foods
$58.66 /

-0.765 (-1.29%)

06/10/20 Credit Suisse
Tyson Foods price target raised to $75 from $70 at Credit Suisse
06/04/20
Fly Intel: Top five analyst upgrades
06/04/20 Bernstein
Tyson Foods upgraded to Outperform with $83 target at Bernstein
LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

07/07/20 KeyBanc
Livongo Health price target raised to $105 from $85 at KeyBanc
07/07/20 Morgan Stanley
Livongo Health price target raised to $89 from $62 at Morgan Stanley
07/07/20 KeyBanc
Livongo Health experiencing higher member enrollment, retention, says KeyBanc
07/06/20 Stephens
Livongo initiated with Overweight, named Best Idea at Stephens
MXL MaxLinear
$25.30 /

+3.41 (+15.58%)

07/07/20 William Blair
William Blair says trends helping MaxLinear likely boosting unit being bought
07/07/20 Roth Capital
MaxLinear price target raised to $25 from $22 at Roth Capital
07/07/20 Needham
MaxLinear price target raised to $33 from $23 at Needham
05/04/20 Craig-Hallum
Craig-Hallum bullish on MaxLinear, initiates with a Buy
EOLS Evolus
$3.86 /

-1.47 (-27.58%)

07/07/20 SunTrust
Evolus price target lowered to $6 from $12 at SunTrust
07/07/20 Mizuho
Evolus downgraded to Neutral from Buy at Mizuho
07/07/20 H.C. Wainwright
Evolus price target lowered to $7 from $15 at H.C. Wainwright
06/02/20 Mizuho
Evolus fundamentals unchanged despite ITC delay, says Mizuho
ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/29/20 Mizuho
AbbVie price target raised to $110 from $101 at Mizuho
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
COMM CommScope
$7.95 /

-0.73 (-8.41%)

07/07/20 Raymond James
CommScope downgraded to Market Perform at Raymond James on valuation
07/07/20 Raymond James
CommScope downgraded to Market Perform from Outperform at Raymond James
07/06/20 Rosenblatt
Samsung on track to replace Nokia as 5G RAN supplier at Verizon, says Rosenblatt
06/25/20 Raymond James
CommScope price target lowered to $10 from $12 at Raymond James
VSLR Vivint Solar
$14.68 /

+4.05 (+38.10%)

TSN Tyson Foods
$58.66 /

-0.765 (-1.29%)

SSP E.W. Scripps
$8.68 /

+0.28 (+3.33%)

SPOT Spotify
$262.11 /

+2.035 (+0.78%)

SIRI Sirius XM
$5.78 /

-0.07 (-1.20%)

SHAK Shake Shack
$49.85 /

-3.53 (-6.61%)

SAFM Sanderson Farms
$113.83 /

+0.56 (+0.49%)

RUN Sunrun
$26.17 /

+4.825 (+22.60%)

REGN Regeneron
$639.90 /

+13.25 (+2.11%)

PPC Pilgrim's Pride
$16.41 /

-0.345 (-2.06%)

NVAX Novavax
$104.58 /

+25.23 (+31.80%)

MXL MaxLinear
$25.30 /

+3.41 (+15.58%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

IHRT iHeartMedia
$7.11 /

-0.02 (-0.28%)

HRL Hormel Foods
$48.15 /

+0.16 (+0.33%)

EOLS Evolus
$3.86 /

-1.47 (-27.58%)

COMM CommScope
$7.95 /

-0.73 (-8.41%)

AMZN Amazon.com
$3,004.68 /

-53.01 (-1.73%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

  • 27
    May
  • 12
    Dec
  • 22
    Nov
  • 07
    Nov
  • 25
    Jul
VSLR Vivint Solar
$14.68 /

+4.05 (+38.10%)

TSN Tyson Foods
$58.66 /

-0.765 (-1.29%)

SSP E.W. Scripps
$8.68 /

+0.28 (+3.33%)

SPOT Spotify
$262.11 /

+2.035 (+0.78%)

SIRI Sirius XM
$5.78 /

-0.07 (-1.20%)

SHAK Shake Shack
$49.85 /

-3.53 (-6.61%)

REGN Regeneron
$639.90 /

+13.25 (+2.11%)

PPC Pilgrim's Pride
$16.41 /

-0.345 (-2.06%)

NVAX Novavax
$104.58 /

+25.23 (+31.80%)

MXL MaxLinear
$25.30 /

+3.41 (+15.58%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

HRL Hormel Foods
$48.15 /

+0.16 (+0.33%)

AMZN Amazon.com
$3,004.68 /

-53.01 (-1.73%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

VSLR Vivint Solar
$14.68 /

+4.05 (+38.10%)

TSN Tyson Foods
$58.66 /

-0.765 (-1.29%)

SPOT Spotify
$262.11 /

+2.035 (+0.78%)

SIRI Sirius XM
$5.78 /

-0.07 (-1.20%)

SHAK Shake Shack
$49.85 /

-3.53 (-6.61%)

SAFM Sanderson Farms
$113.83 /

+0.56 (+0.49%)

RUN Sunrun
$26.17 /

+4.825 (+22.60%)

REGN Regeneron
$639.90 /

+13.25 (+2.11%)

PPC Pilgrim's Pride
$16.41 /

-0.345 (-2.06%)

NVAX Novavax
$104.58 /

+25.23 (+31.80%)

MXL MaxLinear
$25.30 /

+3.41 (+15.58%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

IHRT iHeartMedia
$7.11 /

-0.02 (-0.28%)

HRL Hormel Foods
$48.15 /

+0.16 (+0.33%)

COMM CommScope
$7.95 /

-0.73 (-8.41%)

AMZN Amazon.com
$3,004.68 /

-53.01 (-1.73%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

VSLR Vivint Solar
$14.68 /

+4.05 (+38.10%)

TSN Tyson Foods
$58.66 /

-0.765 (-1.29%)

SPOT Spotify
$262.11 /

+2.035 (+0.78%)

SIRI Sirius XM
$5.78 /

-0.07 (-1.20%)

SHAK Shake Shack
$49.85 /

-3.53 (-6.61%)

RUN Sunrun
$26.17 /

+4.825 (+22.60%)

REGN Regeneron
$639.90 /

+13.25 (+2.11%)

NVAX Novavax
$104.58 /

+25.23 (+31.80%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

HRL Hormel Foods
$48.15 /

+0.16 (+0.33%)

EOLS Evolus
$3.86 /

-1.47 (-27.58%)

COMM CommScope
$7.95 /

-0.73 (-8.41%)

AMZN Amazon.com
$3,004.68 /

-53.01 (-1.73%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

AMZN Amazon.com
$3,004.68 /

-53.01 (-1.73%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:31
07/07/20
07/07
12:31
07/07/20
12:31
NVAX

Novavax

$102.25 /

+22.9 (+28.86%)

, SHAK

Shake Shack

$50.69 /

-2.69 (-5.04%)

, AMZN

Amazon.com

$3,036.79 /

-20.9 (-0.68%)

, WMT

Walmart

$123.57 /

+4.68 (+3.94%)

, SIRI

Sirius XM

$5.81 /

-0.04 (-0.68%)

, SSP

E.W. Scripps

$8.56 /

+0.16 (+1.90%)

, SPOT

Spotify

$264.50 /

+4.425 (+1.70%)

, IHRT

iHeartMedia

$6.85 /

-0.28 (-3.93%)

, RUN

Sunrun

$26.88 /

+5.535 (+25.93%)

, VSLR

Vivint Solar

$14.73 /

+4.1 (+38.57%)

, LVGO

Livongo Health

$92.17 /

+14.6 (+18.82%)

, MXL

MaxLinear

$24.84 /

+2.955 (+13.50%)

, EOLS

Evolus

$3.63 /

-1.7 (-31.89%)

, ABBV

AbbVie

$100.36 /

+1.33 (+1.34%)

, COMM

CommScope

$8.14 /

-0.54 (-6.22%)

The S&P is little…

Open Full Text

ShowHide Related Items >><<
WMT Walmart
$123.57 /

+4.68 (+3.94%)

VSLR Vivint Solar
$14.73 /

+4.1 (+38.57%)

SSP E.W. Scripps
$8.56 /

+0.16 (+1.90%)

SPOT Spotify
$264.50 /

+4.425 (+1.70%)

SIRI Sirius XM
$5.81 /

-0.04 (-0.68%)

SHAK Shake Shack
$50.69 /

-2.69 (-5.04%)

RUN Sunrun
$26.88 /

+5.535 (+25.93%)

NVAX Novavax
$102.25 /

+22.9 (+28.86%)

MXL MaxLinear
$24.84 /

+2.955 (+13.50%)

LVGO Livongo Health
$92.17 /

+14.6 (+18.82%)

IHRT iHeartMedia
$6.85 /

-0.28 (-3.93%)

EOLS Evolus
$3.63 /

-1.7 (-31.89%)

COMM CommScope
$8.14 /

-0.54 (-6.22%)

AMZN Amazon.com
$3,036.79 /

-20.9 (-0.68%)

ABBV AbbVie
$100.36 /

+1.33 (+1.34%)

NVAX Novavax
$102.25 /

+22.9 (+28.86%)

07/07/20 Cantor Fitzgerald
Novavax price target raised to $148 from $88 at Cantor Fitzgerald
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
06/29/20 B. Riley FBR
Novavax price target raised to $106 from $74 at B. Riley FBR
06/29/20 H.C. Wainwright
Novavax price target raised to $101 from $50 at H.C. Wainwright
SHAK Shake Shack
$50.69 /

-2.69 (-5.04%)

06/24/20 JPMorgan
Shake Shack price target raised to $51 from $47 at JPMorgan
05/06/20 Deutsche Bank
Shake Shack price target raised to $57 from $51 at Deutsche Bank
05/05/20 MKM Partners
Shake Shack price target raised to $59 from $50 at MKM Partners
05/05/20 SunTrust
Shake Shack price target raised to $55 from $50 at SunTrust
AMZN Amazon.com
$3,036.79 /

-20.9 (-0.68%)

07/07/20 Baird
Amazon.com price target raised to $3,300 from $2,750 at Baird
07/07/20 Baird
Wayfair price target raised to $225 from $190 at Baird
06/30/20 Mizuho
Amazon.com price target raised to $3,100 from $2,550 at Mizuho
06/29/20 Monness Crespi
Amazon.com price target raised to $3,500 from $2,800 at Monness Crespi
WMT Walmart
$123.57 /

+4.68 (+3.94%)

06/24/20 B. Riley FBR
Hanesbrands products largely sold out at Walmart and Target, says B. Riley FBR
06/22/20 Guggenheim
Walmart price target raised to $145 from $140 at Guggenheim
06/22/20 UBS
Walmart upgraded to Buy from Neutral at UBS
06/03/20 BTIG
Green Dot price target raised to $48 from $40 at BTIG
SIRI Sirius XM
$5.81 /

-0.04 (-0.68%)

07/07/20
Stitcher would help Sirius 'future-proof' business, says B. Riley FBR
06/23/20 B. Riley FBR
Sirius XM estimate raises could drive stock 're-rating,' says B. Riley FBR
06/02/20 JPMorgan
Sirius XM named a top pick for June at JPMorgan
05/19/20 Pivotal Research
Liberty SiriusXM price target lowered to $52 from $63 at Pivotal Research
SSP E.W. Scripps
$8.56 /

+0.16 (+1.90%)

06/25/20 Benchmark
Benchmark sees material benefits if E.W. Scripps sells Stitcher
03/03/20 Wells Fargo
Disney price target lowered to $155 from $180 at Wells Fargo
12/11/19 Guggenheim
Guggenheim says Nexstar, Gray best positioned for 'record' political cycle
SPOT Spotify
$264.50 /

+4.425 (+1.70%)

07/06/20
Fly Intel: Top five analyst downgrades
07/06/20 JPMorgan
Spotify price target raised to $305 from $185 at JPMorgan
07/06/20 Bernstein
Bernstein doubts Spotify will make money off podcasts, downgrades to sell
07/06/20 Bernstein
Spotify downgraded to Underperform from Market Perform at Bernstein
IHRT iHeartMedia
$6.85 /

-0.28 (-3.93%)

07/01/20
Fly Intel: Top five analyst downgrades
07/01/20 BofA
iHeartMedia downgraded to Neutral from Buy at BofA
07/01/20 BofA
iHeartMedia downgraded to Neutral from Buy at BofA
04/23/20 Guggenheim
iHeartMedia price target lowered to $10 from $21.50 at Guggenheim
RUN Sunrun
$26.88 /

+5.535 (+25.93%)

07/07/20 JPMorgan
Sunrun price target raised to $30 from $24 at JPMorgan
07/07/20 JMP Securities
Vivint Solar downgraded to Market Perform from Outperform at JMP Securities
07/06/20 JMP Securities
Sunrun price target raised to $31 from $19 at JMP Securities
06/15/20 Credit Suisse
Sunrun price target raised to $29 from $18 at Credit Suisse
VSLR Vivint Solar
$14.73 /

+4.1 (+38.57%)

06/24/20 Goldman Sachs
Vivint Solar downgraded to Neutral from Buy at Goldman Sachs
06/05/20 JMP Securities
Vivint Solar price target raised to $15 from $10 at JMP Securities
06/02/20 Roth Capital
Roth says loan securitizations reopening a positive for residential solar names
LVGO Livongo Health
$92.17 /

+14.6 (+18.82%)

07/07/20 KeyBanc
Livongo Health price target raised to $105 from $85 at KeyBanc
07/07/20 Morgan Stanley
Livongo Health price target raised to $89 from $62 at Morgan Stanley
07/07/20 KeyBanc
Livongo Health experiencing higher member enrollment, retention, says KeyBanc
07/06/20 Stephens
Livongo initiated with Overweight, named Best Idea at Stephens
MXL MaxLinear
$24.84 /

+2.955 (+13.50%)

07/07/20 William Blair
William Blair says trends helping MaxLinear likely boosting unit being bought
07/07/20 Roth Capital
MaxLinear price target raised to $25 from $22 at Roth Capital
07/07/20 Needham
MaxLinear price target raised to $33 from $23 at Needham
05/04/20 Craig-Hallum
Craig-Hallum bullish on MaxLinear, initiates with a Buy
EOLS Evolus
$3.63 /

-1.7 (-31.89%)

07/07/20 SunTrust
Evolus price target lowered to $6 from $12 at SunTrust
07/07/20 Mizuho
Evolus downgraded to Neutral from Buy at Mizuho
07/07/20 H.C. Wainwright
Evolus price target lowered to $7 from $15 at H.C. Wainwright
06/02/20 Mizuho
Evolus fundamentals unchanged despite ITC delay, says Mizuho
ABBV AbbVie
$100.36 /

+1.33 (+1.34%)

07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/29/20 Mizuho
AbbVie price target raised to $110 from $101 at Mizuho
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
COMM CommScope
$8.14 /

-0.54 (-6.22%)

07/07/20 Raymond James
CommScope downgraded to Market Perform at Raymond James on valuation
07/07/20 Raymond James
CommScope downgraded to Market Perform from Outperform at Raymond James
07/06/20 Rosenblatt
Samsung on track to replace Nokia as 5G RAN supplier at Verizon, says Rosenblatt
06/25/20 Raymond James
CommScope price target lowered to $10 from $12 at Raymond James
WMT Walmart
$123.57 /

+4.68 (+3.94%)

VSLR Vivint Solar
$14.73 /

+4.1 (+38.57%)

SSP E.W. Scripps
$8.56 /

+0.16 (+1.90%)

SPOT Spotify
$264.50 /

+4.425 (+1.70%)

SIRI Sirius XM
$5.81 /

-0.04 (-0.68%)

SHAK Shake Shack
$50.69 /

-2.69 (-5.04%)

RUN Sunrun
$26.88 /

+5.535 (+25.93%)

NVAX Novavax
$102.25 /

+22.9 (+28.86%)

MXL MaxLinear
$24.84 /

+2.955 (+13.50%)

LVGO Livongo Health
$92.17 /

+14.6 (+18.82%)

IHRT iHeartMedia
$6.85 /

-0.28 (-3.93%)

EOLS Evolus
$3.63 /

-1.7 (-31.89%)

COMM CommScope
$8.14 /

-0.54 (-6.22%)

AMZN Amazon.com
$3,036.79 /

-20.9 (-0.68%)

ABBV AbbVie
$100.36 /

+1.33 (+1.34%)

  • 12
    Dec
  • 22
    Nov
  • 07
    Nov
  • 25
    Jul
WMT Walmart
$123.57 /

+4.68 (+3.94%)

VSLR Vivint Solar
$14.73 /

+4.1 (+38.57%)

SSP E.W. Scripps
$8.56 /

+0.16 (+1.90%)

SPOT Spotify
$264.50 /

+4.425 (+1.70%)

SIRI Sirius XM
$5.81 /

-0.04 (-0.68%)

SHAK Shake Shack
$50.69 /

-2.69 (-5.04%)

NVAX Novavax
$102.25 /

+22.9 (+28.86%)

MXL MaxLinear
$24.84 /

+2.955 (+13.50%)

LVGO Livongo Health
$92.17 /

+14.6 (+18.82%)

AMZN Amazon.com
$3,036.79 /

-20.9 (-0.68%)

ABBV AbbVie
$100.36 /

+1.33 (+1.34%)

WMT Walmart
$123.57 /

+4.68 (+3.94%)

VSLR Vivint Solar
$14.73 /

+4.1 (+38.57%)

SPOT Spotify
$264.50 /

+4.425 (+1.70%)

SIRI Sirius XM
$5.81 /

-0.04 (-0.68%)

SHAK Shake Shack
$50.69 /

-2.69 (-5.04%)

RUN Sunrun
$26.88 /

+5.535 (+25.93%)

NVAX Novavax
$102.25 /

+22.9 (+28.86%)

MXL MaxLinear
$24.84 /

+2.955 (+13.50%)

LVGO Livongo Health
$92.17 /

+14.6 (+18.82%)

IHRT iHeartMedia
$6.85 /

-0.28 (-3.93%)

COMM CommScope
$8.14 /

-0.54 (-6.22%)

AMZN Amazon.com
$3,036.79 /

-20.9 (-0.68%)

ABBV AbbVie
$100.36 /

+1.33 (+1.34%)

WMT Walmart
$123.57 /

+4.68 (+3.94%)

VSLR Vivint Solar
$14.73 /

+4.1 (+38.57%)

SPOT Spotify
$264.50 /

+4.425 (+1.70%)

SIRI Sirius XM
$5.81 /

-0.04 (-0.68%)

SHAK Shake Shack
$50.69 /

-2.69 (-5.04%)

RUN Sunrun
$26.88 /

+5.535 (+25.93%)

NVAX Novavax
$102.25 /

+22.9 (+28.86%)

LVGO Livongo Health
$92.17 /

+14.6 (+18.82%)

EOLS Evolus
$3.63 /

-1.7 (-31.89%)

COMM CommScope
$8.14 /

-0.54 (-6.22%)

AMZN Amazon.com
$3,036.79 /

-20.9 (-0.68%)

ABBV AbbVie
$100.36 /

+1.33 (+1.34%)

AMZN Amazon.com
$3,036.79 /

-20.9 (-0.68%)

On The Fly
Fly Intel: Pre-market Movers » 09:11
07/07/20
07/07
09:11
07/07/20
09:11
NVAX

Novavax

$79.35 /

-2.3 (-2.82%)

, CRVS

Corvus Pharmaceuticals

$2.76 /

+0.21 (+8.24%)

, LVGO

Livongo Health

$77.57 /

+4.77 (+6.55%)

, RUN

Sunrun

$21.35 /

+1.35 (+6.75%)

, VSLR

Vivint Solar

$10.63 /

+0.555 (+5.51%)

, ENDP

Endo

$3.62 /

+0.12 (+3.43%)

, REGN

Regeneron

$626.65 /

+5.89 (+0.95%)

, EOLS

Evolus

$5.33 /

-0.15 (-2.74%)

, D

Dominion

$73.60 /

-9.085 (-10.99%)

, ARE

Alexandria Real Estate

$164.78 /

-0.08 (-0.05%)

, COMM

CommScope

$8.68 /

+0.28 (+3.33%)

Check out this morning's…

Open Full Text

ShowHide Related Items >><<
VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

RUN Sunrun
$21.35 /

+1.35 (+6.75%)

REGN Regeneron
$626.65 /

+5.89 (+0.95%)

NVAX Novavax
$79.35 /

-2.3 (-2.82%)

LVGO Livongo Health
$77.57 /

+4.77 (+6.55%)

EOLS Evolus
$5.33 /

-0.15 (-2.74%)

ENDP Endo
$3.62 /

+0.12 (+3.43%)

D Dominion
$73.60 /

-9.085 (-10.99%)

CRVS Corvus Pharmaceuticals
$2.76 /

+0.21 (+8.24%)

COMM CommScope
$8.68 /

+0.28 (+3.33%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

NVAX Novavax
$79.35 /

-2.3 (-2.82%)

07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
06/29/20 B. Riley FBR
Novavax price target raised to $106 from $74 at B. Riley FBR
06/29/20 H.C. Wainwright
Novavax price target raised to $101 from $50 at H.C. Wainwright
06/19/20 Cantor Fitzgerald
Novavax price target raised to $88 from $45 at Cantor Fitzgerald
CRVS Corvus Pharmaceuticals
$2.76 /

+0.21 (+8.24%)

03/10/20 H.C. Wainwright
Corvus Pharmaceuticals initiated with a Buy at H.C. Wainwright
12/09/19 Mizuho
Corvus pipeline updates 'can only be additive,' says Mizuho
09/12/19 Mizuho
Mizuho starts Corvus Pharmaceuticals with Buy rating, $7 price target
09/11/19 Mizuho
Corvus Pharmaceuticals initiated with a Buy at Mizuho
LVGO Livongo Health
$77.57 /

+4.77 (+6.55%)

07/07/20 KeyBanc
Livongo Health experiencing higher member enrollment, retention, says KeyBanc
07/06/20 Stephens
Livongo initiated with Overweight, named Best Idea at Stephens
07/02/20
Fly Intel: Top five analyst downgrades
07/02/20 Goldman Sachs
Livongo Health downgraded to Neutral from Buy at Goldman Sachs
RUN Sunrun
$21.35 /

+1.35 (+6.75%)

07/07/20 JMP Securities
Vivint Solar downgraded to Market Perform from Outperform at JMP Securities
07/06/20 JMP Securities
Sunrun price target raised to $31 from $19 at JMP Securities
06/15/20 Credit Suisse
Sunrun price target raised to $29 from $18 at Credit Suisse
06/02/20 Roth Capital
Roth says loan securitizations reopening a positive for residential solar names
VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

06/24/20 Goldman Sachs
Vivint Solar downgraded to Neutral from Buy at Goldman Sachs
06/05/20 JMP Securities
Vivint Solar price target raised to $15 from $10 at JMP Securities
ENDP Endo
$3.62 /

+0.12 (+3.43%)

06/17/20 Citi
Sell Mallinckrodt, buy Endo with opioid risk coming back, says Citi
04/24/20
Fly Intel: Top five analyst initiations
04/24/20 Citi
Endo initiated with a Buy at Citi
01/03/20 Piper Sandler
Endo upgraded to Overweight from Neutral at Piper Jaffray
REGN Regeneron
$626.65 /

+5.89 (+0.95%)

07/01/20 Oppenheimer
Regeneron price target raised to $675 from $625 at Oppenheimer
06/24/20 Credit Suisse
Regeneron price target raised to $700 from $605 at Credit Suisse
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
06/18/20 Piper Sandler
AbbVie atopic dermatitis data a postive, says Piper Sandler
EOLS Evolus
$5.33 /

-0.15 (-2.74%)

07/07/20 SunTrust
Evolus price target lowered to $6 from $12 at SunTrust
07/07/20 Mizuho
Evolus downgraded to Neutral from Buy at Mizuho
07/07/20 H.C. Wainwright
Evolus price target lowered to $7 from $15 at H.C. Wainwright
06/02/20 Mizuho
Evolus fundamentals unchanged despite ITC delay, says Mizuho
D Dominion
$73.60 /

-9.085 (-10.99%)

07/07/20 Argus
Dominion price target lowered to $80 from $87 at Argus
07/07/20 Mizuho
Dominion downgraded to Underperform from Neutral at Mizuho
07/07/20 Credit Suisse
Dominion downgraded to Neutral from Outperform at Credit Suisse
07/06/20 Wells Fargo
Wells says merits of Dominion's 'forward-looking' deal to be clearer with time
ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

06/08/20 JMP Securities
Alexandria Real Estate resumed with an Outperform at JMP Securities
02/04/20 Mizuho
Alexandria Real Estate assumed with a Buy at Mizuho
12/18/19 JPMorgan
JPMorgan makes 17 REIT rating changes in conjunction with 2020 outlook
12/18/19 RBC Capital
Alexandria Real Estate downgraded to Outperform from Top Pick at RBC Capital
COMM CommScope
$8.68 /

+0.28 (+3.33%)

07/07/20 Raymond James
CommScope downgraded to Market Perform at Raymond James on valuation
07/07/20 Raymond James
CommScope downgraded to Market Perform from Outperform at Raymond James
07/06/20 Rosenblatt
Samsung on track to replace Nokia as 5G RAN supplier at Verizon, says Rosenblatt
06/25/20 Raymond James
CommScope price target lowered to $10 from $12 at Raymond James
VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

RUN Sunrun
$21.35 /

+1.35 (+6.75%)

REGN Regeneron
$626.65 /

+5.89 (+0.95%)

NVAX Novavax
$79.35 /

-2.3 (-2.82%)

LVGO Livongo Health
$77.57 /

+4.77 (+6.55%)

EOLS Evolus
$5.33 /

-0.15 (-2.74%)

ENDP Endo
$3.62 /

+0.12 (+3.43%)

D Dominion
$73.60 /

-9.085 (-10.99%)

CRVS Corvus Pharmaceuticals
$2.76 /

+0.21 (+8.24%)

COMM CommScope
$8.68 /

+0.28 (+3.33%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

  • 07
    Jul
  • 27
    May
  • 07
    Jan
  • 12
    Dec
  • 07
    Nov
  • 25
    Jul
VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

REGN Regeneron
$626.65 /

+5.89 (+0.95%)

NVAX Novavax
$79.35 /

-2.3 (-2.82%)

LVGO Livongo Health
$77.57 /

+4.77 (+6.55%)

ENDP Endo
$3.62 /

+0.12 (+3.43%)

D Dominion
$73.60 /

-9.085 (-10.99%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

RUN Sunrun
$21.35 /

+1.35 (+6.75%)

REGN Regeneron
$626.65 /

+5.89 (+0.95%)

NVAX Novavax
$79.35 /

-2.3 (-2.82%)

LVGO Livongo Health
$77.57 /

+4.77 (+6.55%)

ENDP Endo
$3.62 /

+0.12 (+3.43%)

D Dominion
$73.60 /

-9.085 (-10.99%)

COMM CommScope
$8.68 /

+0.28 (+3.33%)

ARE Alexandria Real Estate
$164.78 /

-0.08 (-0.05%)

VSLR Vivint Solar
$10.63 /

+0.555 (+5.51%)

RUN Sunrun
$21.35 /

+1.35 (+6.75%)

REGN Regeneron
$626.65 /

+5.89 (+0.95%)

NVAX Novavax
$79.35 /

-2.3 (-2.82%)

LVGO Livongo Health
$77.57 /

+4.77 (+6.55%)

EOLS Evolus
$5.33 /

-0.15 (-2.74%)

ENDP Endo
$3.62 /

+0.12 (+3.43%)

D Dominion
$73.60 /

-9.085 (-10.99%)

COMM CommScope
$8.68 /

+0.28 (+3.33%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.